Jemvesta M 5/500mg Tablet

jemvesta M 5/500mg Tablet is a combination medication containing two active ingredients: EMPAGLIFLOZIN + METFORMIN HCI. It is prescribed for the management of type 2 diabetes by addressing blood sugar levels through different mechanisms.

Active Ingredients:

• Empagliflozin (5mg):
  • Empagliflozin is a sodium-glucose co-transporter-2 (SGLT2) inhibitor. It reduces glucose reabsorption in the kidneys, leading to increased glucose excretion in urine.
• Metformin Hydrochloride (500mg):
  • Metformin is a biguanide that helps improve insulin sensitivity, reduce glucose production in the liver, and enhance glucose uptake by tissues.

Used For:

1. Type 2 Diabetes Management: Jemvesta M is prescribed to individuals with type 2 diabetes to help control blood sugar levels.
2. Dual Action: The combination of Empagliflozin and Metformin provides dual action by addressing glucose reabsorption and improving insulin sensitivity.

Dosage and Administration:

• The dosage is typically determined by healthcare providers based on individual response and medical condition.
• Tablets are usually taken orally, with or without food, as directed by the healthcare provider.

Side Effects:

Common side effects may include urinary tract infections, increased urination, and gastrointestinal disturbances. Consult with a healthcare professional if any adverse reactions persist.

When Not to Use:

1. Kidney Impairment: Jemvesta M is not recommended for individuals with severe kidney impairment.
2. Allergies: Individuals with known allergies to Empagliflozin, Metformin, or related components should avoid this medication.

Precautions and Warnings:

1. Dehydration: Caution is advised in individuals at risk of dehydration, such as those taking diuretics or with significant fluid loss.
2. Lactic Acidosis: Monitor for signs of lactic acidosis, especially in individuals with conditions that may predispose them to this risk.

JEMVESTA M 5/500MG TABLET (EMPAGLIFLOZIN + METFORMIN HCI) – FAQs

Q1: How does Jemvesta M 5/500mg Tablet help in managing type 2 diabetes?

A: Jemvesta M combines Empagliflozin and Metformin HCI. Empagliflozin reduces glucose reabsorption in the kidneys, and Metformin improves insulin sensitivity, collectively aiding in type 2 diabetes management.

Q2: What is the recommended dosage for Jemvesta M 5/500mg Tablet?

A: The recommended dosage is determined by healthcare providers based on individual response and medical condition. Adherence to the prescribed dosage is crucial for effective diabetes management.

Q3: Can Jemvesta M 5/500mg Tablet be taken as a monotherapy for diabetes?

A: Jemvesta M is often prescribed as part of a comprehensive treatment plan for type 2 diabetes. Consult with your healthcare provider for personalized advice on diabetes management.

Q4: Are there specific precautions for individuals with kidney impairment using Jemvesta M?

A: Jemvesta M is not recommended for individuals with severe kidney impairment. Regular monitoring and adjustment of the dosage may be necessary. Consult with your healthcare provider for personalized advice.

Q5: Can Jemvesta M 5/500mg Tablet be taken with other diabetes medications?

A: Inform your healthcare provider about all medications, including over-the-counter drugs and supplements, to avoid potential interactions. Your healthcare provider can guide you on the appropriate combination therapies.